Arthritis suffers need to be aware that recent studies indicate that some arthritis pain-relievers have been linked to higher mortality rates from ischemic strokes.
I want to draw attention to a recent study that was conducted on someArthritis Pain Relievers drugs and stroke outcomes. The research, which was published in Neurology – the official journal of the American Academy of Neurology, looked at the use of non-aspirin non-steroidal anti-inflammatory drugs, (NSAIDs), prior to hospital admission and stroke mortality rates.
Arthritis Pain Relievers Tied To Stroke Deaths
There are many different types of NSAIDs prescribed for relieving pain and some of the newer versions of these drugs have already been removed from pharmacy shelves. However, older NSAIDs are still on the market and often used to control arthritis pain. The study published in Neurology looked at old and newer selective NSAIDs, called COX-2 inhibitors, as well as other “non-selective” NSAIDs such as ibuprofen and naproxen.
The researchers, led by Dr. Morten Schmidt, concluded that pre-admission use of COX-2 was connected with a higher 30-day mortality rate after ischemic stroke, though not from hemorrhagic stroke. Use of non-selective NSAIDs (ibuprofen and naproxen) was not associated with higher mortality rates from stroke.
In saying on the results of the study, Dr. Schmidt said, “Our study proves further important evidence solidifying the risks of certain arthritic pain relievers and death from stroke.”
This study arthritis pain relievers is particularly important for many reasons, not the least of which is that both arthritis and stroke are afflictions that attack the elderly more than any other segment of the population. While arthritis is a painful and often crippling, no one would associate it with being a deadly condition, unless of course you have a stroke and have been taking particular types of arthritis pain-relievers tied to stroke deaths. And, there is no getting around the fact that older people suffer more strokes than anyone else and stroke is the fourth leading cause of death in the U.S. this is showing that arthritis pain relievers are tied to stroke deaths
that Arthritis Pain Relievers The drugs looked at in the study were: diclofenac, etodolac, nabumeton, meloxicam, celecobix, and rofecoxib. Research on these drugs found that current users of COX-2 inhibitors were 19 percent more likely to die after stroke than people who did not take these drugs; new users of older COX-2 drugs were 42 percent more likely to die from stroke than those who weren’t taking them; people who took etodolac were 53 percent more likely to die from stroke because the arthritis pain relievers are accosiated with stroke.
If you or a member of your family has arthritis and you are taking any of these medications for pain, you should probably talk to your doctor and ask about the raised death rates from stroke after using these drugs. There are other pain relievers on the market that won’t put you at higher risk of death in the event you have a stroke.
This study is also important for anyone whose friend or family member might have died from stroke and was taking any of these medications prior to their stroke incident. There is no reason why these drugs should still be on the market given the evidence that their use is associated with higher death rates in stroke victims. Stroke misdiagnosis and delayed work of stroke is all too common and can be responsible for life-long disabilities in stroke victims.
The information posted here on StrokeLaw.com is not to be interpreted as providing legal services or as proposing any form of legal advice. Nor should it be interpreted as offering any form of medical advice. All content is strictly intended for informational purposes only.